Marinus Pharmaceuticals Stock Forward View

Marinus Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Marinus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Marinus using various technical indicators. When you analyze Marinus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Marinus Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Marinus Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Marinus Pharmaceuticals Naive Prediction Price Forecast For the 3rd of February

Given 90 days horizon, the Naive Prediction forecasted value of Marinus Pharmaceuticals on the next trading day is expected to be 0.62 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.91.

Marinus Pharmaceuticals Stock Forecast Pattern

Backtest Marinus Pharmaceuticals

Marinus Pharmaceuticals Price Prediction

Research Analysis

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Marinus Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Marinus Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Marinus Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Marinus Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Marinus Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Marinus Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.55 0.55 0.55 Details

Intrinsic Valuation Low Real High 0.40 0.40 0.61 Details

Bollinger Band Projection (param) Low Middle High 0.53 0.54 0.55 Details

Marinus Pharmaceuticals After-Hype Price Density Analysis

Marinus Pharmaceuticals Estimiated After-Hype Price Volatility

Marinus Pharmaceuticals Stock Price Outlook Analysis

Notes

Marinus Pharmaceuticals Hype Timeline

Marinus Pharmaceuticals is now traded for 0.55. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Marinus is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.0%. %. The volatility of related hype on Marinus Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 0.55. About 83.0% of the company shares are owned by institutional investors. The book value of Marinus Pharmaceuticals was now reported as 0.31. The company recorded a loss per share of 2.47. Marinus Pharmaceuticals last dividend was issued on the 23rd of September 2020. The entity had 1:4 split on the 23rd of September 2020. Given the investment horizon of 90 days the next estimated press release will be in about 7 days. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in small area income & poverty estimates.

Marinus Pharmaceuticals Related Hype Analysis

Marinus Pharmaceuticals Related Equities

Risk & Return

Correlation

Marinus Pharmaceuticals Market Strength Events

Marinus Pharmaceuticals Risk Indicators

Story Coverage note for Marinus Pharmaceuticals

Marinus Pharmaceuticals Short Properties

Other Consideration for investing in Marinus Stock